The Effects of Inhaled Nitric Oxide on Patient Morbidity and Length of Hospital Stay Following Fontan Operation

Trial Profile

The Effects of Inhaled Nitric Oxide on Patient Morbidity and Length of Hospital Stay Following Fontan Operation

Completed
Phase of Trial: Phase II/III

Latest Information Update: 27 Apr 2016

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Pleural effusion
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 May 2012 Actual patient number added 21 according to ClinicalTrials.gov.
    • 03 May 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.
    • 03 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top